Caris Life Sciences, Inc. (CAI) Soars 81% YoY with $181M Q2 Revenue
Caris Life Sciences, Inc.
Cai International Inc. (CAI)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (CAI) is currently associated with the following stock: Caris Life Sciences Inc. (CAI)
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Donald Smith & Co., Inc. Richard Greenberg And Jon Hartsel | 0 | $0 | 0% | |
| 2. | Walleye Capital Will England | 0 | $0 | 0% | |
| 3. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% | |
| 4. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 5. | D E Shaw D. E. Shaw | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.74 | 100 | $2,274.00 | 81,507 | 2019-02-27 | Filing | |
| $22.24 | 10,508 | $233,697.92 | 81,407 | 2019-02-26 | Filing | |
| $24.23 | 1,000 | $24,230.00 | 52,882 | 2018-06-01 | Filing | |
| $24.25 | 9,000 | $218,250.00 | 51,882 | 2018-06-01 | Filing | |
| $25.00 | 2,079 | $51,975.00 | 12,000 | 2018-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.57 | 10,403 | $286,810.71 | 38,771 | 2020-11-02 | Filing | |
| $28.70 | 11,651 | $334,383.70 | 30,718 | 2019-12-17 | Filing | |
| $23.71 | 50,000 | $1,185,600.00 | 16,703 | 2019-11-22 | Filing | |
| $23.23 | 10,000 | $232,300.00 | 6,757 | 2019-03-29 | Filing | |
| $22.81 | 1,225,214 | $27,947,131.34 | 0 | 2018-05-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
Strong Performance Lifted Caris Life Sciences (CAI) in Q2
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test
A pivotal development came with the FDA approval of Caris’s MI Cancer Seek platform, the first diagnostic to combine whole exome and whole transcriptome sequencing on a single test for both adult and...
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
Mario Gabelli is Doubling Down on These 5 Stocks
In this article, we discuss the 5 stocks that Mario Gabelli is doubling down on.
Hedge Funds Are Piling Into CAI International Inc (CAI)
In this article we will check out the progression of hedge fund sentiment towards CAI International Inc (NYSE:CAI) and determine whether it is a good investment right now.
Were Hedge Funds Right About CAI International Inc (CAI)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is CAI A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Keep Selling CAI International Inc (CAI)
In this article you are going to find out whether hedge funds think CAI International Inc (NYSE:CAI) is a good investment right now.
Hedge Fund Resource Center Billionaire Hedge Funds
